|
NCCN Guidelines® Insights - Esophageal and Esophagogastric Junction Cancers, Version 4.2026 |
1.00 |
09/16/2026 - 12:00am to 09/10/2027 - 11:59pm |
|
NCCN Guidelines® Insights - Hepatocellular Carcinoma, Version 2.2026 |
1.00 |
10/13/2026 - 12:00am to 10/10/2027 - 11:59pm |
|
Archived NCCN Tumor Boards: Induction Therapy for Ph+ B-Cell Acute Lymphoblastic Leukemia |
1.00 |
10/13/2026 - 12:00am to 10/08/2027 - 11:59pm |
|
NCCN Tumor Boards: Advances in the Management of Early-Stage and Locally Advanced Cervical Cancer |
1.00 |
10/21/2026 - 12:00am to 04/04/2027 - 11:59pm |
|
NCCN Tumor Boards: Select Updates in the Treatment of Multiple Myeloma |
1.00 |
10/21/2026 - 12:00am to 02/21/2027 - 11:59pm |
|
Recorded Presentation of NCCN Optimizing Patient Outcomes - Management of Bispecific T-Cell Engager Toxicities: How to Balance Increased Efficacy... |
1.00 |
10/27/2026 - 12:00am to 10/16/2027 - 11:59pm |
|
Comprehensive Pain Management in Oncology: A Multidisciplinary Approach |
|
10/31/2026 - 12:00am to 10/30/2027 - 11:59pm |
|
Chronic Lymphocytic Leukemia: Navigating First-Line and MRD-Guided Treatment Options |
0.75 |
11/02/2026 - 12:00am to 11/01/2027 - 11:59pm |
Facebook
X
LinkedIn
Forward